Iterum Therapeutics Limited, a clinical-stage pharmaceutical company focused on the development and commercialization of drugs to treat patients with infectious diseases, today confirmed a $1.5 million award to support the...
Iterum Therapeutics Limited, a clinical-stage pharmaceutical company focused on the development and commercialization of drugs to treat patients with infectious diseases, today confirmed a $1.5 million award to support the...
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat...
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2017 second quarter financial results on Tuesday, August 8, 2017, after the close of the financial markets. Company management will host a...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2017 second quarter financial results on Tuesday, August 8, 2017, after the close of the financial markets. Company management will host a...
Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to fostering of technology, today announced that it has closed its previously announced firm...
Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to fostering of technology, today announced that it has closed its previously announced firm...
Genome Medical, a nationwide genetic medical practice, today announced the launch of "Genetic Navigator," a telemedicine service that offers consumers virtual access to a network of clinical genetic experts. The service is...
Genome Medical, a nationwide genetic medical practice, today announced the launch of "Genetic Navigator," a telemedicine service that offers consumers virtual access to a network of clinical genetic experts. The service is...
BioLight Life Sciences Ltd. (TASE: BOLT) ("BioLight"), an emerging global ophthalmic company focused on the discovery, development and commercialization of ophthalmic products and product candidates, announced today...
BioLight Life Sciences Ltd. (TASE: BOLT) ("BioLight"), an emerging global ophthalmic company focused on the discovery, development and commercialization of ophthalmic products and product candidates, announced today...
The "CT Scanner Market by Type (Stationary, Portable), Architecture (C-arm, O-arm), Technology (High, Mid, Low Slice, CBCT), Application (Human, Veterinary, Research), End User - Global Forecast to 2022" report has been...
The "CT Scanner Market by Type (Stationary, Portable), Architecture (C-arm, O-arm), Technology (High, Mid, Low Slice, CBCT), Application (Human, Veterinary, Research), End User - Global Forecast to 2022" report has been...
Hyundai Hope On Wheels® will present the Hasbro Children's Hospital of Providence with a $50,000 Hyundai Impact Award. Hasbro Children's Hospital is one of 25 recipients of this year's award, which is given to...
Hyundai Hope On Wheels® will present the Hasbro Children's Hospital of Providence with a $50,000 Hyundai Impact Award. Hasbro Children's Hospital is one of 25 recipients of this year's award, which is given to...
Hyundai Hope On Wheels® will present Joe DiMaggio Children's Hospital of Hollywood, FL with a $50,000 Hyundai Impact Award. The facility, part of the Memorial Healthcare System, is one of 25 recipients of this...
Hyundai Hope On Wheels® will present Joe DiMaggio Children's Hospital of Hollywood, FL with a $50,000 Hyundai Impact Award. The facility, part of the Memorial Healthcare System, is one of 25 recipients of this...
The "Global Breast Imaging Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Breast Imaging Market is poised to grow at a CAGR of around...
The "Global Breast Imaging Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Breast Imaging Market is poised to grow at a CAGR of around...
The "Global Bone Growth Stimulator Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Bone Growth Stimulator Market is poised to grow at a...
The "Global Bone Growth Stimulator Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Bone Growth Stimulator Market is poised to grow at a...
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of a once-daily, oral therapy for the treatment of nonalcoholic steatohepatitis,...
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of a once-daily, oral therapy for the treatment of nonalcoholic steatohepatitis,...
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading cryogenic logistics company dedicated to the life sciences industry, today announced that the Company will report financial results for the second...
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading cryogenic logistics company dedicated to the life sciences industry, today announced that the Company will report financial results for the second...
Some of the key players operating in the global Tissue Engineered Collagen Biomaterials Market are Collagen Matrix Inc., Medtronic, Advanced BioMatrix Inc., Kyeron B.V., Collagen Matrix, Collagen Solutions Plc., CollPlant...
Some of the key players operating in the global Tissue Engineered Collagen Biomaterials Market are Collagen Matrix Inc., Medtronic, Advanced BioMatrix Inc., Kyeron B.V., Collagen Matrix, Collagen Solutions Plc., CollPlant...
ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that its wholly-owned foreign enterprise, CBD Biotechnology Co....
ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announces that its wholly-owned foreign enterprise, CBD Biotechnology Co....
DelMar Pharmaceuticals (Nasdaq: DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the Human Genetic Resources Administration of China...
DelMar Pharmaceuticals (Nasdaq: DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the Human Genetic Resources Administration of China...
Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® C. difficile Assay, a moderate complexity, sample to answer test for rapid detection of C. difficile. The ARIES® C....
Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® C. difficile Assay, a moderate complexity, sample to answer test for rapid detection of C. difficile. The ARIES® C....
Shionogi & Co., Ltd. (hereafter "Shionogi") has announced that S-033188, a novel cap-dependent endonuclease inhibitor targeting influenza, demonstrated superiority to placebo in a global Phase 3 study in otherwise...
Shionogi & Co., Ltd. (hereafter "Shionogi") has announced that S-033188, a novel cap-dependent endonuclease inhibitor targeting influenza, demonstrated superiority to placebo in a global Phase 3 study in otherwise...
Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the European Medicines Agency (EMA) has granted Toca 511 (vocimagene amiretrorepvec) PRIME (PRIority MEdicines)...
Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the European Medicines Agency (EMA) has granted Toca 511 (vocimagene amiretrorepvec) PRIME (PRIority MEdicines)...
MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage immuno-oncology drug development company with a fully human antibody discovery platform focused on the rapid translation into clinical development of...
MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage immuno-oncology drug development company with a fully human antibody discovery platform focused on the rapid translation into clinical development of...
Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that it will report its second quarter 2017 financial results on Monday, August 7, 2017 and will host a conference...
Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that it will report its second quarter 2017 financial results on Monday, August 7, 2017 and will host a conference...
Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced today that results on HIV susceptibility to ibalizumab from the Phase IIb trial, TMB-202, along with new findings for EGRIFTA® (tesamorelin for injection), are...
Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced today that results on HIV susceptibility to ibalizumab from the Phase IIb trial, TMB-202, along with new findings for EGRIFTA® (tesamorelin for injection), are...
WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today announced preliminary financial results for the three months ended June 30, 2017.
WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today announced preliminary financial results for the three months ended June 30, 2017.
In a unique non-profit crowd funding campaign, 2redWinery, makers of the award-winning Zinpiphany© Zinfandel and #2red, is currently crowd funding the 2017 vintage on Indiegogo with all proceeds supporting prostate cancer...
In a unique non-profit crowd funding campaign, 2redWinery, makers of the award-winning Zinpiphany© Zinfandel and #2red, is currently crowd funding the 2017 vintage on Indiegogo with all proceeds supporting prostate cancer...
HOUSTON and VANCOUVER, July 24, 2017 /PRNewswire/ - ESSA Pharma Inc. (TSX: EPI; NASDAQ: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on the development of novel small molecule drugs for...
HOUSTON and VANCOUVER, July 24, 2017 /PRNewswire/ - ESSA Pharma Inc. (TSX: EPI; NASDAQ: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on the development of novel small molecule drugs for...
Eli Lilly and Company (NYSE: LLY) and Nektar Therapeutics (NASDAQ: NKTR) have announced a strategic collaboration to co-develop NKTR-358, a novel immunological therapy discovered by Nektar. NKTR-358, which achieved first...
Eli Lilly and Company (NYSE: LLY) and Nektar Therapeutics (NASDAQ: NKTR) have announced a strategic collaboration to co-develop NKTR-358, a novel immunological therapy discovered by Nektar. NKTR-358, which achieved first...
Fluicell AB, a pioneering high-tech company in single-cell biology, is extremely delighted to announce the issuance of US Patent No 9,6719,671,366, entitled "Pipettes, methods of use, and methods of stimulating an object...
Fluicell AB, a pioneering high-tech company in single-cell biology, is extremely delighted to announce the issuance of US Patent No 9,6719,671,366, entitled "Pipettes, methods of use, and methods of stimulating an object...
The "Temperature Management Market - Forecast to 2022" report has been added to Research and Markets' offering. The global temperature management market is projected to reach USD 2.72 Billion by 2022 from USD 2.40...
The "Temperature Management Market - Forecast to 2022" report has been added to Research and Markets' offering. The global temperature management market is projected to reach USD 2.72 Billion by 2022 from USD 2.40...
The "Global Cystic Fibrosis Therapeutics Market Outlook 2022" report has been added to Research and Markets' offering. The Market for Cystic Fibrosis Therapeutics was Valued at US$ 1.94 Billion in 2016 The report...
The "Global Cystic Fibrosis Therapeutics Market Outlook 2022" report has been added to Research and Markets' offering. The Market for Cystic Fibrosis Therapeutics was Valued at US$ 1.94 Billion in 2016 The report...
STA Pharmaceutical Co., Ltd. (STA) – a WuXi AppTec subsidiary and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing – announces it signed a supply...
STA Pharmaceutical Co., Ltd. (STA) – a WuXi AppTec subsidiary and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing – announces it signed a supply...
The "Bioanalytical Testing Services Market Analysis By Molecule-Type (Small Molecule, Large Molecule), By Test Type (ADME, PK, PD, Bioavailability, Bioequivalence), By Region, And Segment Forecasts, 2014 - 2025" report has...
The "Bioanalytical Testing Services Market Analysis By Molecule-Type (Small Molecule, Large Molecule), By Test Type (ADME, PK, PD, Bioavailability, Bioequivalence), By Region, And Segment Forecasts, 2014 - 2025" report has...
The "Global Bioadsorbable Stents Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Bioadsorbable Stents Market is poised to grow at a CAGR...
The "Global Bioadsorbable Stents Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Bioadsorbable Stents Market is poised to grow at a CAGR...
Boehringer Ingelheim announced a $217 million investment to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and highly-skilled positions to the City of...
Boehringer Ingelheim announced a $217 million investment to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and highly-skilled positions to the City of...
The Lupus Research Alliance congratulates GlaxoSmithKline (GSK) on the approval of belimumab (Benlysta®) by the U.S. Food and Drug Administration as a self-injectable (subcutaneous) formulation for people with systemic...
The Lupus Research Alliance congratulates GlaxoSmithKline (GSK) on the approval of belimumab (Benlysta®) by the U.S. Food and Drug Administration as a self-injectable (subcutaneous) formulation for people with systemic...
Canada's Licensed Cannabis Producers partner to develop cannabis advertising and branding guidelines that will allow Canadians to be informed about responsible use, protect public health and safety
Canada's Licensed Cannabis Producers partner to develop cannabis advertising and branding guidelines that will allow Canadians to be informed about responsible use, protect public health and safety
GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody-positive SLE who are...
GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody-positive SLE who are...
The "Global Portable Medical Equipment Market 2017-2021" report has been added to Research and Markets' offering. The global portable medical equipment market to grow at a CAGR of 8.86% during the period 2017-2021. ...
The "Global Portable Medical Equipment Market 2017-2021" report has been added to Research and Markets' offering. The global portable medical equipment market to grow at a CAGR of 8.86% during the period 2017-2021. ...
The "Global Retinal Drugs Market 2017-2021" report has been added to Research and Markets' offering. The global retinal drugs market to grow at a CAGR of 11.66% during the period 2017-2021. The report, Global...
The "Global Retinal Drugs Market 2017-2021" report has been added to Research and Markets' offering. The global retinal drugs market to grow at a CAGR of 11.66% during the period 2017-2021. The report, Global...
Senate Republicans introduced a revised version of the health care repeal aiming to replace the Affordable Care Act earlier this month. Repealing the law was a top priority for Mr. Trump and Republicans in Congress,...
Senate Republicans introduced a revised version of the health care repeal aiming to replace the Affordable Care Act earlier this month. Repealing the law was a top priority for Mr. Trump and Republicans in Congress,...
The report "Medical Packaging Market by Material (Polymer, Non-woven Fabric, Paper & Paperboard), Packaging Type (Bags & Pouches, Trays, Boxes), Application (Medical Equipment & Tools, Medical Devices,...
The report "Medical Packaging Market by Material (Polymer, Non-woven Fabric, Paper & Paperboard), Packaging Type (Bags & Pouches, Trays, Boxes), Application (Medical Equipment & Tools, Medical Devices,...
The "Global Pre-filled Syringes Market 2017-2021" report has been added to Research and Markets' offering. The global pre-filled syringes market to grow at a CAGR of 10.07 % during the period 2017-2021. Global...
The "Global Pre-filled Syringes Market 2017-2021" report has been added to Research and Markets' offering. The global pre-filled syringes market to grow at a CAGR of 10.07 % during the period 2017-2021. Global...
AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has granted a positive opinion for HUMIRA®...
AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has granted a positive opinion for HUMIRA®...
Novavax, Inc. (Nasdaq: NVAX) today announced it will host a conference call and webcast on Monday, July 24, 2017, at 4:30 p.m. ET. Novavax anticipates receiving results and announcing topline data from its Phase 2 safety...
Novavax, Inc. (Nasdaq: NVAX) today announced it will host a conference call and webcast on Monday, July 24, 2017, at 4:30 p.m. ET. Novavax anticipates receiving results and announcing topline data from its Phase 2 safety...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, announced that Julie Cooke is joining as Chief People Officer in September 2017 and will be a...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, announced that Julie Cooke is joining as Chief People Officer in September 2017 and will be a...
IBM (NYSE: IBM) scientists and the University of Alberta in Edmonton, Canada, have published new data in Nature's partner journal, Schizophrenia1, demonstrating that AI and machine learning algorithms helped predict...
IBM (NYSE: IBM) scientists and the University of Alberta in Edmonton, Canada, have published new data in Nature's partner journal, Schizophrenia1, demonstrating that AI and machine learning algorithms helped predict...
Revenue Prospects by Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others) Radioisotope (Tc-99, F-18, I-131, Lu-177, Y-90, Ga-68, Ga-67, Rb-82, I-123, I-125, I-111,...
Revenue Prospects by Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others) Radioisotope (Tc-99, F-18, I-131, Lu-177, Y-90, Ga-68, Ga-67, Rb-82, I-123, I-125, I-111,...
VANCOUVER, July 21, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its unaudited results for the quarter ended June 30, 2017, on Wednesday, August 2, 2017 after...
VANCOUVER, July 21, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its unaudited results for the quarter ended June 30, 2017, on Wednesday, August 2, 2017 after...
VLP Therapeutics, LLC ("VLP"), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced the appointment of Jacob Licht as Chief...
VLP Therapeutics, LLC ("VLP"), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced the appointment of Jacob Licht as Chief...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that the Committee for Medicinal Products for Human Use (CHMP), the committee of the European Medicines Agency (EMA) responsible for human medicines, has...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that the Committee for Medicinal Products for Human Use (CHMP), the committee of the European Medicines Agency (EMA) responsible for human medicines, has...
Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) ("Marapharm" or the "Company") (http://www.marapharm.com/) owns, without debt, 1.22 acres in Southern California (announced June 12, 2017) with an approved...
Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) ("Marapharm" or the "Company") (http://www.marapharm.com/) owns, without debt, 1.22 acres in Southern California (announced June 12, 2017) with an approved...
Not intended for UK-based media If approved, avelumab could be the first immunotherapy treatment indicated for this rare and aggressive skin cancer in the EU Decision by the EC is expected in the third quarter of 2017...
Not intended for UK-based media If approved, avelumab could be the first immunotherapy treatment indicated for this rare and aggressive skin cancer in the EU Decision by the EC is expected in the third quarter of 2017...
Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for 14 percent of total...
Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand medicines, generics and the supply chain account for 14 percent of total...
If you want a Stock Review on AUPH, ESPR, PRTK, or VSTM then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Focus is on the Biotech industry, which broadly segments...
If you want a Stock Review on AUPH, ESPR, PRTK, or VSTM then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Focus is on the Biotech industry, which broadly segments...
The "Pediatric Drugs and Vaccines - Global Strategic Business Report" report has been added to Research and Markets' offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...
The "Pediatric Drugs and Vaccines - Global Strategic Business Report" report has been added to Research and Markets' offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...
Novartis today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for AMG 334 (erenumab) for the prevention of migraine in patients experiencing four or...
Novartis today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for AMG 334 (erenumab) for the prevention of migraine in patients experiencing four or...
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at...
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at...
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 25, 2017, after the close of the U.S. financial markets. The announcement will be followed by a conference call...
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 25, 2017, after the close of the U.S. financial markets. The announcement will be followed by a conference call...
The "Pharmaceutical Packaging Market Analysis By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil), By Product (Primary, Secondary, Tertiary), By End-use And Segment Forecasts, 2014 - 2025"...
The "Pharmaceutical Packaging Market Analysis By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil), By Product (Primary, Secondary, Tertiary), By End-use And Segment Forecasts, 2014 - 2025"...
The "Global Intra Abdominal Pressure Measurement Device Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering. The global intra...
The "Global Intra Abdominal Pressure Measurement Device Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering. The global intra...
The "Global Surgical/Operating Microscopes Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering. The global surgical/operating...
The "Global Surgical/Operating Microscopes Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering. The global surgical/operating...
Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry will present its global initiative, "Partnering Today for a Stronger Tomorrow," at the 69th American Association for Clinical Chemistry...
Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry will present its global initiative, "Partnering Today for a Stronger Tomorrow," at the 69th American Association for Clinical Chemistry...
CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced it has been granted a Notice of Allowance from the European Patent Office (EPO) for its patent application...
CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced it has been granted a Notice of Allowance from the European Patent Office (EPO) for its patent application...
Churchill Pharmaceuticals, LLC (Churchill), a privately held company devoted to expanding treatment options with oral oncology agents, announces that the New Drug Application (NDA) for YONSA™ (abiraterone acetate)...
Churchill Pharmaceuticals, LLC (Churchill), a privately held company devoted to expanding treatment options with oral oncology agents, announces that the New Drug Application (NDA) for YONSA™ (abiraterone acetate)...
Paragon Bioservices, a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today the appointment of Deborah Wild to the position of Vice President, Quality and Regulatory Affairs, where she...
Paragon Bioservices, a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today the appointment of Deborah Wild to the position of Vice President, Quality and Regulatory Affairs, where she...
The "Global Leukemia Therapeutics Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Leukemia Therapeutics Market is poised to grow at a CAGR...
The "Global Leukemia Therapeutics Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Leukemia Therapeutics Market is poised to grow at a CAGR...
If you want a Stock Review on ACAD, ADRO, AGIO, or AVXS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Today's attention is redirected to the Biotechnology...
If you want a Stock Review on ACAD, ADRO, AGIO, or AVXS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Today's attention is redirected to the Biotechnology...
EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the receipt of a European Patent Certificate. ...
EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the receipt of a European Patent Certificate. ...
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV), and the UNISEC consortium today reported statistically significant positive results from the Phase 2b clinical trial of M-001, BiondVax's universal flu vaccine...
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV), and the UNISEC consortium today reported statistically significant positive results from the Phase 2b clinical trial of M-001, BiondVax's universal flu vaccine...
AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, today announced it has entered into a Development and License Agreement...
AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, today announced it has entered into a Development and License Agreement...
LEO Pharma today announced that the European Commission has granted marketing authorisation for Kyntheum® (brodalumab), a new biologic for the treatment of moderate-to-severe plaque psoriasis in adults within the European...
LEO Pharma today announced that the European Commission has granted marketing authorisation for Kyntheum® (brodalumab), a new biologic for the treatment of moderate-to-severe plaque psoriasis in adults within the European...
Laser Prostate Centers of America (LPCA) is a team of expert urologists and interventional radiologists moving prostate cancer detection and treatment into the twenty-first century with the introduction of the latest in...
Laser Prostate Centers of America (LPCA) is a team of expert urologists and interventional radiologists moving prostate cancer detection and treatment into the twenty-first century with the introduction of the latest in...
Aspyrian Therapeutics, Inc., a biotechnology company developing precision-targeted cancer therapies based on the proprietary Photoimmunotherapy (PIT) platform, has closed $15.1 million as part of a Series B-1 financing...
Aspyrian Therapeutics, Inc., a biotechnology company developing precision-targeted cancer therapies based on the proprietary Photoimmunotherapy (PIT) platform, has closed $15.1 million as part of a Series B-1 financing...
With the addition of two mobile sites, the Government has now authorized 14 supervised consumption sites in Canada to help address the opioid crisis
With the addition of two mobile sites, the Government has now authorized 14 supervised consumption sites in Canada to help address the opioid crisis
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today announced positive results from a 12-month Phase 3 safety study of revefenacin (TD-4208), an...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today announced positive results from a 12-month Phase 3 safety study of revefenacin (TD-4208), an...
The "Global Medical Gas Equipment Market 2017-2021" report has been added to Research and Markets' offering. The global medical gas equipment market to grow at a CAGR of 7.57% during the period 2017-2021. The...
The "Global Medical Gas Equipment Market 2017-2021" report has been added to Research and Markets' offering. The global medical gas equipment market to grow at a CAGR of 7.57% during the period 2017-2021. The...
The "Preimplantation Genetic Testing Market - Forecast to 2022" report has been added to Research and Markets' offering. The global preimplantation genetic testing market is expected to reach USD 541.8 Million by 2022...
The "Preimplantation Genetic Testing Market - Forecast to 2022" report has been added to Research and Markets' offering. The global preimplantation genetic testing market is expected to reach USD 541.8 Million by 2022...
Neurotrope, Inc. (NASDAQ: NTRP) today presented clinical results from its recently completed Phase 2 trial demonstrating that moderate-to-severe Alzheimer's disease (AD) patients treated with 20 µg bryostatin-1 showed...
Neurotrope, Inc. (NASDAQ: NTRP) today presented clinical results from its recently completed Phase 2 trial demonstrating that moderate-to-severe Alzheimer's disease (AD) patients treated with 20 µg bryostatin-1 showed...
TE Connectivity Ltd. (NYSE: TEL), a world leader in connectivity and sensors, released its seventh annual Global Corporate Responsibility Report today, outlining the company's progress in providing superior...
TE Connectivity Ltd. (NYSE: TEL), a world leader in connectivity and sensors, released its seventh annual Global Corporate Responsibility Report today, outlining the company's progress in providing superior...
Oracle NetSuite Global Business Unit, one of the world's leading providers of cloud-based financials / ERP, HR, Professional Services Automation (PSA) and omnichannel commerce software suites, today announced that it...
Oracle NetSuite Global Business Unit, one of the world's leading providers of cloud-based financials / ERP, HR, Professional Services Automation (PSA) and omnichannel commerce software suites, today announced that it...
A few months ago, MouthWatch, LLC sent an intraoral camera to Dr. Sarah Cimino, a general dentist who works with a Ronald McDonald Care Mobile to reach underserved kids in the Ozarks. Focused on dental care, the "Tooth...
A few months ago, MouthWatch, LLC sent an intraoral camera to Dr. Sarah Cimino, a general dentist who works with a Ronald McDonald Care Mobile to reach underserved kids in the Ozarks. Focused on dental care, the "Tooth...
FORMULATRIX® announced today that the next generation CONSTELLATION® Digital PCR System will be revealed at the qPCR and Digital PCR Congress in Philadelphia on July 25th, 2017. "Based on customer feedback, we have built...
FORMULATRIX® announced today that the next generation CONSTELLATION® Digital PCR System will be revealed at the qPCR and Digital PCR Congress in Philadelphia on July 25th, 2017. "Based on customer feedback, we have built...
Imago BioSciences, a clinical-stage pharmaceutical company developing novel anti-cancer therapies, announced today that the first patients have been dosed in the Phase 2a portion of their clinical trial of IMG-7289 for the...
Imago BioSciences, a clinical-stage pharmaceutical company developing novel anti-cancer therapies, announced today that the first patients have been dosed in the Phase 2a portion of their clinical trial of IMG-7289 for the...
The Leukemia & Lymphoma Society (LLS) today announced the expansion of its groundbreaking precision medicine Beat AML® Master Trial, to test new, investigational treatments for acute myeloid leukemia (AML), the central...
The Leukemia & Lymphoma Society (LLS) today announced the expansion of its groundbreaking precision medicine Beat AML® Master Trial, to test new, investigational treatments for acute myeloid leukemia (AML), the central...
Medic Vision, the pioneer and US market leader in 3rd party XR-29 standard solutions, announced today that it was granted a patent by the US Patent and Trademark Office on its XR-29 Dose-Check system (Patent No. 9693747),...
Medic Vision, the pioneer and US market leader in 3rd party XR-29 standard solutions, announced today that it was granted a patent by the US Patent and Trademark Office on its XR-29 Dose-Check system (Patent No. 9693747),...
Lifetrack Medical Systems Inc. has been awarded a US Patent entitled "Managing Permissions" that greatly improves workflow adaptability and security management of enterprise applications, while maintaining simplicity in...
Lifetrack Medical Systems Inc. has been awarded a US Patent entitled "Managing Permissions" that greatly improves workflow adaptability and security management of enterprise applications, while maintaining simplicity in...
The Corporate Whistleblower Center says, "We are urging a physician or healthcare manager to call us anytime at 866-714-6466 if they can prove a hospital is improperly providing incentives to medical doctors for referring...
The Corporate Whistleblower Center says, "We are urging a physician or healthcare manager to call us anytime at 866-714-6466 if they can prove a hospital is improperly providing incentives to medical doctors for referring...
Henry Schein, Inc., (Nasdaq: HSIC) today unveiled a newly designed website for Henry Schein Medical (www.henryschein.com/medical), the company's medical division, and announced an improved e-commerce solution with a...
Henry Schein, Inc., (Nasdaq: HSIC) today unveiled a newly designed website for Henry Schein Medical (www.henryschein.com/medical), the company's medical division, and announced an improved e-commerce solution with a...
Axovant Sciences (NYSE: AXON) today announced new data from a preclinical study which suggests that intepirdine may have neuroprotective properties against vascular injury and neuronal metabolic dysfunction (poster...
Axovant Sciences (NYSE: AXON) today announced new data from a preclinical study which suggests that intepirdine may have neuroprotective properties against vascular injury and neuronal metabolic dysfunction (poster...
China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release second quarter...
China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release second quarter...
Epidemiologists conducting national precision medicine initiatives focused on gathering clinical research data on genetic variation among East and South Asian populations now have access to Thermo Fisher Scientific's...
Epidemiologists conducting national precision medicine initiatives focused on gathering clinical research data on genetic variation among East and South Asian populations now have access to Thermo Fisher Scientific's...
ModGene Pharma, LLC today announced the issuance of US Patent 9,707,231, entitled "Compositions and Methods for Reduction of Amyloid-beta Load." The claims cover the use of an imatinib-related compound for reduction of...
ModGene Pharma, LLC today announced the issuance of US Patent 9,707,231, entitled "Compositions and Methods for Reduction of Amyloid-beta Load." The claims cover the use of an imatinib-related compound for reduction of...
Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill[TM] platform technology, announces that the Patent Registry...
Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill[TM] platform technology, announces that the Patent Registry...
Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to fostering of technology and monetization of intellectual property, today announced that it has...
Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to fostering of technology and monetization of intellectual property, today announced that it has...
Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat...
Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat...
A new report released by the Virgin Group today, Future Visions, explores what the world of business will look like in 20 years' time. The findings reveal our the world we live in will see pre-emptive crime prevention,...
A new report released by the Virgin Group today, Future Visions, explores what the world of business will look like in 20 years' time. The findings reveal our the world we live in will see pre-emptive crime prevention,...
If you want a Stock Review on RNN, PLX, NAVB, or BSTG then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Pre-market, DailyStockTracker.com scans Rexahn...
If you want a Stock Review on RNN, PLX, NAVB, or BSTG then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Pre-market, DailyStockTracker.com scans Rexahn...
If you want a Stock Review on AGN, IRWD, MDCO, or CTLT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The Generic Drugs market can be segmented into biosimilars,...
If you want a Stock Review on AGN, IRWD, MDCO, or CTLT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The Generic Drugs market can be segmented into biosimilars,...
EIP Pharma, LLC (www.eippharma.com) today announced that new mechanism of action data regarding neflamapimod were presented at the AAIC 2017 scientific meeting in London, UK (July 16-20, 2017; https://www.alz.org/aaic/). ...
EIP Pharma, LLC (www.eippharma.com) today announced that new mechanism of action data regarding neflamapimod were presented at the AAIC 2017 scientific meeting in London, UK (July 16-20, 2017; https://www.alz.org/aaic/). ...
ResearchMoz has released a new publication, titled "Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market", explains the rate at...
ResearchMoz has released a new publication, titled "Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market", explains the rate at...
The Alzheimer's Association today announced the launch of a $20 million U.S. two-year clinical trial to test the ability of a multi-dimensional lifestyle intervention to prevent cognitive decline and dementia in 2,500...
The Alzheimer's Association today announced the launch of a $20 million U.S. two-year clinical trial to test the ability of a multi-dimensional lifestyle intervention to prevent cognitive decline and dementia in 2,500...
